Search

This review provides a comprehensive summary of evidence to explore the role and value of differential diagnosis in the management of Acute Respiratory Infections (ARIs) through point-of-care (POC) rapid testing in a post-pandemic scenario, paying particular attention to coronavirus disease 2019 (COVID-19), influenza, and respiratory syncytial virus (RSV). The document builds on a review of literature and policies and a process of validation and feedback by a group of seven experts from Latin America (LATAM). Evidence was collected to understand scientific and policy perspectives on the differential diagnosis of ARIs and POC rapid testing, with a focus on seven countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru. The evidence indicates that POC rapid testing can serve to improve ARI case management, epidemiological surveillance, research and innovation, and evidence-based decision-making. With multiple types of rapid tests available for POC, decisions regarding which tests to use require the consideration of the testing purpose, available resources, and test characteristics regarding accuracy, accessibility, affordability, and results turnaround time. Based on the understanding of the current situation, this document provides a set of recommendations for the implementation of POC rapid testing in LATAM, supporting decision-making and guiding efforts by a broad range of stakeholders. [ABSTRACT FROM AUTHOR]

The article focuses on prioritizing neglected infectious diseases (NIDs) research on two countries such as Latin America and Caribbean Region. It states that the NIDs elimination and reduction goal has been set by the Pan American Health Organization (PAHO) in American countries. It mentions several indicators that could be utilized in prioritizing NIDs related research including the indicators of poverty, mortality, and disease morbidity. It says that identifying the technological strengths and opportunities in Latin America and the Caribbean (LAC) is believed to be the second approach in prioritizing medical research for NIDs mentioning that the researches and technological networks in the area might contribute to a new cost-effective research action concerning NIDs.

Despite political turmoil and economical crisis, research in Latin America has considerably advanced over recent decades. The present ‘Point of View’ outlines our perspectives on the working conditions, successes, difficulties, limitations, and challenges of biomedical scientific communities in four Latin American countries: Argentina (G.A.R.), Brazil (M.L.), Chile (A.K.), and Mexico (Y.R.). [ABSTRACT FROM AUTHOR]